Thesis
Reference
Control by protein phosphorylation and G proteins of calcium oscillations, and pituitary hormone secretion
CHIAVAROLI, Carlo
Abstract
Le corps humain est composé d'environ 1250 g de calcium, la quasi totalité se trouvant dans les os sous forme d'hydroxyapatite [Ca10(PO4)6(OH)2], assurant la rigidité de notre squelette. En plus de ce rôle constitutionnel, le calcium sous sa forme ionisée ou libre (quelques grammes du calcium total présent dans le corps) est un élément dynamique de première importance pour le bon fonctionnement de l'organisme: c'est un messager secondaire. La concentration de calcium libre dans l'espace extracellulaire, [Ca2+]e, est 10000 fois plus élevée que la concentration intracellulaire cytosolique, [Ca2+]i, (environ 1mM et 100 nM respectivement). Lorsqu'un signal externe (le messager primaire: une hormone par exemple) parvient à sa cellule cible et reconnaît son récepteur il induit dans de nombreux systèmes cellulaires une modification transitoire de la [Ca2+]i. Il est connu depuis longtemps que le calcium est un élément essentiel pour la sécrétion des cellules endocrines. Le développement de sondes fluorescentes sensibles aux ions Ca2+, telles que le fura-2, a permis d'effectuer des études temporelles et [...]
CHIAVAROLI, Carlo. Control by protein phosphorylation and G proteins of calcium oscillations, and pituitary hormone secretion. Thèse de doctorat : Univ. Genève, 1992, no.
Sc. 2545
DOI : 10.13097/archive-ouverte/unige:102346
Available at:
http://archive-ouverte.unige.ch/unige:102346
Disclaimer: layout of this document may differ from the published version.
l!
i
j
io
UNIYERSITE DE GENEVE FACULTE DE MEDECINE
Fondation pour Recherches
Médicales
Docteur W. SchlegelFACULTE
DESSCIENCES
Département de Biochimie Professeur M. BalllvetCONTROL BY PROTEIN PHOSPHORYLATION AND G PROTEINS OF CALCIUM OSCILLATIONS,
AND PITUITARY HORMONE SECRETION
THESE
présentée à ta Faculté des Sclences de I'Unlversité de Genève
pour obtenlr te grailede Docteur ès'Sclencest mention blochimlque
Carlo CHIAVAROLI
de Montegrlmano (Italte)
thèse No 2545
pâr
UNIVERSITE DE GENEVE FACULTE DE MEDECINE
Fondation pour Recherches
Médicales
Docteur W. SchlegelFACULTE
DESSCIENCES
Département de Biochimie Professeur M. BallivetCONTROL BY PROTEIN PHOSPHORYLATION AND G PROTEINS OF CALCIUM OSCILLATIONS,
AND PITUITARY HORMONE SECRETION
THESE
présentée à ta Faculté des Sciences de I'Université de Genève
pour obtenir Ie grade de Docteur ès Sciences, mention biochimique
Carlo CHIAVAROLI
de Montegrimano (Italie)
Thèse No 2545
GENEVE par
UNIVERSITÉ DE
G ENÈVT
FACULTÉ DES SCIENCES
Doclorat ès sclences menlion biochimiclue
Thèse de ltlonsieur Carlo CHIAVAROLI
intitulée
:''CONTROL BY PROTEIN PHOSPHORYLATION AND G PROTEINS OF CALCTUM OSCILLATIONS, AND
PITUITARY HORMONE SECRETION.''
La Faculté des Sciences, sur le préavis de Messieurs W.
SCHLEGEL'maître
d'enseignementet de recherche (Facutté de Médecine -
Fondationpour recherches médicales) et M. BALLIVET, professeur ordinaire
(Département.de biochimie) codirecteurs de thèse et B. DUFY,
docteur(Université de Bordeaux, France), autorise I'impression de la
présentethèse,
sansexprimer d'opinion sur les propositions qui y sont
énoncées.Genève,
le
6juillet
1992Thèse - 2545
Le Doyen, Pierre
BURIA Ctaire
Felix qui potuit rerum cognoscere causas
Remerciements
Je tiens à remercier tout particulièrement et très chaleureusement le Dr. Werner Schlegel pour sa disponibilité et sa gentillesse naturelle, ainsi que pour la qualité de ses nombreux conseils
qu'il
m'a prodigués tout au long de cette thèse. Pour moiil
sera toujours un modèle et un ami.J'exprime également toute ma reconnaissance au Dr. Gaston Zahndpour
m'avoir
accueilli à la Tulipe, ainsi qu'aux Profs. Claes Wollheim, DermotCooper, Bob Clark et Daniel [,ew pour leurs
judicieux
conseils.J'adresse de même mes remerciements au Prof. Marc
Ballivet
et au Dr.Bernard
Dufy
pouravoir
accepté de corriger ce travail et de fonctionner comme jurés officiels.J'aimerais également remercier les Drs. Nicolas Demaurex, Pierre Vacher, Yvan Lagnaux,
Karl-Heinz
Krause, PatriceMollard,
Jean-Marc Theler,Ro semary Murray-Whelan, Mari sa Jaconi, Françoi se A s simacopoulo s, Stephen Rawlings et
William
Pralong pour les entretiens bénéfiques dontj'ubénéficiê
durant cette thèse.
Toute ma gratitude va aussi à Isabelle Piuz pour son assistance
impeccable et sa
disponibilité
ainsi qu'à Jacqueline Derrien, Nathalie Guérineau et Mardjan Hezarehpour leur aide efficace, sans oublier bien sûr toutes les personnes, qui de près ou deloin m'ont
assisté durant cesquelçes
années.Pour terminer
je
tiens àféliciter
ma femme Nathalie pour moavoir supporté durant ces longues années, ainsi que mes parents, Ernesto et Marina, dont les sacrifices, acceptés avec le sourire sont aujourd'hui finalementrécompensés.
Content
I. Reader's guide
II. Preface
III. Introduction
1. Adenopiruitary cells, an overview
1.1 Clonal cells derived
from
the adenopituitary2. Stimulus-secretion coupling: the concept
2.I.
Thestimuli:
hypothalamic factors2.l.L
Activatorsof
secretion2.I.2. Inhibitors of
secretion 2.2. Cell surface receptors3. Heterotrimeric guanine nucleotide-binding proteins 3.1 Mechanism
of
G proteins activation3.2. Sub-classes of heterotrimeric G proteins
3.2.t.
TheG.
sub-class 3.2.2.Th"
Gi sub-class 3.2.3. The Gt sub-class 3.2.4. The Go sub-class3.2.5. The other sub-classes
of
G proteins4. Two important effectors coupled to G proteins 4.1. Phospholipase C
4.2.
Adenylyl cyclasep.7
p.8
p.9 p.9 p.12
p.12 p.
13p.
13p.17 p.
18p.20 p.22 p.25 p.25 p.25
p. z7
p.27 p.28
p.29
p.29
p.30
5. Calcium ions as cytosolic messenger
5. 1. Cytosolic calcium-binding proteins
5.2.Proteins that transport
C**
through membranes5.2.L.The
Ca2+-AIPase5.2.2. The Na+/C
**
exchanger of the plasma membrane5 .2.3 . Calcium channels 5.3. Intracellular stores
5.3. 1. Endoplasmic
reticulum
5 .3.2. Sarcoplasmic
reticulum
5.3.3.Mitochondria
5.4. Examples
of lC**limodification in
clonalpituitary
cells5.4.L
Action
potential and spontaneous [Ca2*]i oscillations 5.4.2. [Ca2*]i modification by an hormone6. Some other second messengers 6.1.
cAMP
and protein kinaseA
6.2.
Inositol
phosphates6.2.I.
Role ofIns(l,4,5)Ps
andIns(l ,3,4,5)P4in
[Ca2*]i homeostasis6.3.
Diacylglycerol
and protein kinase C7. Protein phosphatases
8. Secretion
p.32
p. 35
p.36
p. 36
p.37 p.37
p.
4r p.41 p.43 p.45 p.46 p.46
p. 47
p.50 p.50
p. 53 p. 55
p.56
p. 58
p.59
IV. Experimental Approaches
1. Fluorescent dyes
l.I
Fwa-Z excitation spectrum 2. Setupfor
[Ca2+Ji measurementsV. Publications Publication I:
Modulation
of calciuminflux
by proteinphosphorylation
in
single intact clonalpituitary
cells.p.62 p.62 p.65 p.67
p.69 p.70
Publication II: p.95
Simultaneous monitoring
of
cytosolicfree calcium and exocytosis at the single cell level.
Publication III: P.120
Spontaneous [Ca2+1i oscillations and G. expression are inversely correlated
with
secretory granule content inpituitary
cells.VI. Synthesis p.
150VII. References
p. 155p. r93
VIIL Résumé de thèse
I. Reader's guide
This
work
dealswith
theregulation
of endocrine secretion.It
was performed on adenopituitary cells, which control many functions such as growth, metabolism, lactation, stress, sexual development, etc.In
theintroduction,
wewill
first recall the physiological contextof pituitary
hormone secretion andits
control by the hypothalamus. Travelling along the pathwaysfor
"stimulus-secretion coupling" wewill
describe the nature of the hypothalamic agents which influencepituitary
cells, some plasmamembrane receptors, the proteins (G proteins) that transduce the message
in
the plasma membrane after the occupancy of a receptor, some of the effectorsactivated, and the second messengers generated. The elements involved in the regularion
of
the inrracellular levelof C*+
([Ca2*]i)will
be largely discussed.Then we
will contnue
ourtrip looking
at protein kinases and phosphatases, whichmodify
upon activation, the release of pituitary hormones.A brief "Experimental Approaches"
sectionwill follow,
explaining essentially how to measure the levelof
;Ca2+1,in
single cells.Three
pubtications produced during this
thesisform
the core ofthis work.
Each contains Introduction, Materials and Methods, Results, andDiscussion sections.
A
shortfinal
synthesis, dealingwith
the regulationof
[Ca2+]l oscillationsII. Preface
There is an analogy between
politics
and the endocrine system.Usually
in
a stable democratic government, tasks need to be defined preciselyin
order to avoid anarchy. The same is true
in
biology.The endocrine system is composed
of
several glands (pituitary, thyroid, parathyroid, adrenal, gonads, pancreas, etc.) located in different areas of the body that produce hormoneswith
different functions. These glands, which arerichly
vascularized,release their secretory products directly into the bloodstream.The anterior
pituitary
is under the control of the hypothalamus.If
we compare the hypothalamus to the President of the endocrine system, the adeno-pituitary
can be viewed as the Prime Minister. This gland produces majorhormones (laws) which regulate the physiology of the other glands (the regional governments). Once secreted
into
the blood the pituitary hormones bind to the surface of target cells, whichin
turn increase the synthesis and the secretionof
peripheral hormones (regional laws).
A
democratic government should be attentive to the reaction of the citizen of the counffy. People can manifestif
they do not agreewith
thepolicy
chosen by their leaders. The endocrine system is also regulated by feed-back reactrons.
We
will
now describebriefly
the laws ordered by the Prime Minister,following
a request of the President, and see whatwill
happenin
the counffy.How
will
these laws be applied? Howwill
the people react?Later on, and this is the main part of this work, we
will
be interestedin
how the PrimeMinister
did get the request from the President, and how he managed,with
the helpof
a battery of lawyers to promulgate the laws.III. Introduction
L. Adenopituitary cells, an overview
The
pituitary (from
600 to 900 mgin
the man) is a composed of two lobes, the anterior (the adenopituitary) and the posterior (the neuropituitary). The adenopituitary representsT5Vo of the total mass. Adenopituitary cells are under the control of hypothalamic agents which act either by stimulating orinhibiting
secretion. These epithelial cells can secrete 6 major different hormones. Once secretedinto
the blood ttrepituitary
hormones bind to the surface of target cells, whichin
turn increase the synthesis and the secretion of peripheral hormones, leading to the activation orinhibition
of many cellular functions(fig.
1).Prolactin
(PRL, 198 aa), wasoriginally
thought of only for its role in theinitiation
and maintenance of lactation.It
has now been found to have a wide range of physiological activities. Prolactin by enhancing the release of prolactin-inhibiting
factors controls its own secretion (see Lamberts andMacleod,
1990)for
a complete review of the regulation of PRL secretion).Growth hormone
(GH, somatotropin, 1"91 aa) stimulates theliver
to produce somatomedin-l (also calledinsulin-like
growthfactor-l),
whichin
turn controls the growth of body tissues such as bone, cartilage, muscle, etc.Thyroid-stimulating hormone
(TSH,c-chain
92 aa, B-chain 115 aa), stimulates thethyroid
gland to produce thyroid hormones andfatty
acid releaseFotlicte-stimulating hormone
(FSH, a-chain 92aa, B-chain 118 aa), acts on ovarianfollicles
to grow and secrete esffadiol and stimulates also spennato- genesisin
testis.Luteinizing-hormone (LH,
cr-chain 92 aa, B-chain 115 aa), stimulates oocyte maturation and ovulation aswell
as progesterone secretion from ovary, and stimulates testis to produce testosterone.Adrenocorticotropic hormone (ACTH,39
aa), increases the productionof
cortisol by the adrenal cortex andfatty
acid release from fat cells. Thishormone is the key component
in
theconffol
of the stress response.It
has been thoughtfor
many years that a single adenopituitary cell could secrete only one hormone type. This led to ttre concept of 66one cell type, one hormonett. However, recent evidences, based on reversehemolytic
plaque as- say experiments (RHPA), have revealed that a single pituitary cell can secrete both GH and PRL (Frawley and al., 1985).This technique is based on the
following:
a monolayerof
cells issurrounded by erythrocytes manipulated to bind the hormone secreted by the cells.
To this end the erythrocytes are coated
with
specific antibodies against the secreted hormone. Upon stimulation by a secretagogue, an immune complex is produced around the erythrocytesin
theproximity
of secreting cells. In presence of the complement system the erythrocytes are lysed, and a radial zone is then clearlyvisible
around the secreting cells.PITUITARY HYPOTHALAMUS
THYROID
BREAgT
TSH
, ACTH GH
PRL LH
FSH Growth
Factors GROWTH
I
Fig.
1..Hormones
secreted bythe adenopituitary.
L.L. Clonal cells derived from the adenopituitary
Due to the large heterogeneity of the adenopituitary cells,
in
most of the workpituitary
cell lines derived from rat adenopituitary tumors were used, such as the clones GH3B6 andGHaCI
(Thshjian et al., 1968). These cells produce and secrete spontaneowly invitro
only PRL andGH
(Tashjian, 1979). They have preserved theirability
to respond to several hypothalamic or steroid hormonesin
a manner analogous to normal anterior
pituitary
cells. Using reverse hemolytic plaque assayit
was shown that a single clonal cell can secrete either just one type of hormone (PRL, GH) or both hormones (Boocfor and Schwartz, 1988).2. Stimulus-secretion coupling: the concept
The concept of excitation-conffaction coupling (Sandow 1952),
developed for muscle, has found its endocrine countelpart, the stimulus-secretion coupling, some years later (Douglas, 1968).
This term
refersto
a chainof biochemical
mechanismslinking
aninitial
event, thestimulus, to
endocrine secretion. Adenopituitary cells are an excellent modelfor
the study of the stimulus-secretion coupling. Cells communicatewith
each other by a varietyof
signal molecules, such as neurotransmitters, hormones and growth factors, that are detected by specific receptors on the plasma membrane
of
the target cell.Important
stimuli
acting on thepituitary
are mostly from hypothalamic origin.The hypothalamus communicates directly
with
the adenopituitarypituitary via
the portal blood system.2.1".
The stimuli: hypothalamic factors 2.LJ. Activators of secretion
Thyrotropin-Releasing-Honnone
(TRH) is a tripeptide exffactedfrom
the hypothalamus(Nair etal.,1970).
This oligopeptide is a powerful stimulator of TSH and PRL secretion (see Lamberts andMacleod for
review 1990).TRH
binds to a single class of receptors. The binding affrnity is compatiblewith
its secretagogue effect (Gershengorn, 1982). The binding of TRH to its receptor is thefirst
step of the signalling cascade which leads to secretion (fig. 2). This pathway includes the activation of a G protein which activates in turn the phospholipase C (PLC). This lead to the cleavage of phospholipidphosphatidylinositol4,5-bisphosphate
(PIP/
and to the production ofinositol I,4,5
trisphosphate (Ins( 1,4,5)P3) and L-2-dracylglycerol (DG). The former diffrrsesin
the cytosol and promotesCah mobilization frominternal
stores, and DG staysin
thelipid
bilayer and activates protein kinase C (PKC), animportant stimulator of many cellular functions, which can be
itself
activated byC**
(Nishizuka,1984). PKC is able to phosphorylate voltage-dependent calcium channels of theL-type (L-VDCC),
and promotes Ca2*influx. In
pituitary
cellsin
primary structure, TRH was found to increase secretion of PRLwithin
4 s. The secretory pattern apparentin
a cell population isbiphasic
(Bj6ro et al., 1990).A
similar patternof
secretion is foundin
clonal cells (Aizawa andHinkle,
1985).+ +
@ TRII
RTRH
GTP GDP
lCa
2+IP3
2+
Ca
1
/
2+I
i
/
Ca
L. VDCC
Many cellular
responsesincluding PRL
secretion@-t'@...
Fig.2.
Mechanisms ofTRII
action. See textfor
explanations.Vasoactive
Intestinal
Peptide(VIP)
is a 28-amino acid residue and wasoriginally
extracted from pork intestine (Said and Porter, 1979), whereit
plays a rolein
the regulation of bicarbonate secretion (Flemstrom et al., 1985).It
was also detectedin
great amountsin
the hypothalamus (Besson eta1.,I979).In pituitary
cellsit
stimulates the secretion of PRL, GH andACTH
(Gourdji et al.,1979; Enjalbert et al, 1980; Matsushita et a7., 1981; White et al., 1982, Abe et al., 1985).
Uponbinding
to its receptor (49 Kd), VIP activates the guanine nucleotide binding protein G. whichin
turn stimulates adenylyl cyclase and hence increasescAMP
accumulationwithin
the cells (Gourdji et a1.,1979). This leads to the activation of protein kinaseA (PKA),
akey
eîzyme of the metabolism.PKA
then phosphorylates some voltage-dependent calcium channels and promotesC** entry (fig.
3, Changet
al.,I99I).In
contrast to TRH, the secretory pattern obtained afterVIP
stimulation is monophasic, secretion starts after a a lag time of 45-60 s (BjOro et al., 1990).Some observations suggest that
VIP
could act on the same cells that produce and releaseit,
as an autocrine factor. IndeedVIP
is produced in thepituitary
gland (Arnaout et al., 1986), where the peptide might have some autore- gulatory role in prolactin secretion (I.{agy et al., 1988).@ VIP
RVIP
GTP GDP ATP
CAMPlCa
2+1I
Ca 2+I
\ L. VDCC
Many cellular
responsesincluding PRL
secretion@tt@...
Fig.
3. Mechanisms ofVIP action.
See text for explanation2.L.2. Inhibitors of secretion
Dopamine
is a powerfulinhibitor
of PRL secretion (e.g. Luque et al., 1986).It
is produced by the hypothalamus. Its action may be modulated through both the adenylyl cyclase andthe
Ca2* mobilization/phosphoinositide pathways.Dopamine
inhibits
adenylyl cyclase (Stoof and Kebabian, 1984) and alsoC**
mobilization induced by
TRH
(Schofield, 1983), a potent activator of PRL secretion.It
appears that they are two classesof
dopamine receptors, the one presentin
thepituitary
gland is the D-2rcceptor. Interestin
D-2 receptors stems largelyfrom
the involvementin
the pathology of neurological andpsychiaric
disorders such as parkinsonism (Kebabian and Calne, 1979). This receptor is also ttre targetof
drugs used to alleviate the main symptomsof
schizophrenia (See- man, 1980).The neurotransmitter
y-aminobutyric
acid(GABA)
inhibits PRL secretion by activating voltage-dependent Cl- channels (Inenaga and Mason,I987aand b). As a consequence the cell is hyperpolari zed, Ca2+ can not enter through voltage-dependent calcium channels of the L-type and the secretion is impeded.
Somatostatin
(SRIF) is a teffadecapeptide secreted by hypothalamic neurons.It inhibits
both basal and stimulated PRL, TSH,ACTH
and GH releasein pituitary
cells (Vale et a1., 1974; Patel and Srikant, 1986). SRIF acrs byThe presence of
esradiol
is essentialfor
somatostatin toinhibit
PRL secretion.In
fact, estradiol directly regulates the number
of
somatostatin receptorsin
lactotrophs (Kimura et d..,1986).
Pituitary
cellsin
culture usually respond to somatostatin evenin
the absenceof
any added esffadiol. This is explained by the presencein
the culture medium of phenol red, a pH indicator, which can mimic the effects of esffadiol (Hofland etal.,
1987).Adenosine is produced and released by most animal cells, and acts as a
modulator
of
cellular activity. In the CNS adenosine acts via A1 receptors toinhibit
adenylyl cyclase (Londos et al., 1980) and hence neurotransmitters release.In
clonalpituitary
cells, adenosine inhibits PRL and GH release(Dorflinger and Schonbrunn, 1985) by abolishingCa2+ transients linked to action potentials (Cooper et
al.,
1989;Mollard
et a1.,1991).2.2. Cell surface receptors
The first step
in
stimulus-secretion coupling is the activationof
one receptor by a specific ligand. Fischer's theory of the"lock
and key" has evolved andit
is clear today that receptors are proteins showing an intrinsic highmalleability of
structure (the Koshland's "induced-fit model"). This allows the discrimination between an extraordinary variety of chemical signals. The binding of the ligand induces a subtle changein
the conformation of the receptor, and the signalling cascade is switched on. Most cell-surface receptors belong to oneof
three classes, which are defined by the ffansduction mechanism used.
Channel-linked
receptors (ex: the acetylcholine receptor) areffansmitter-gated
ion
channels involved for rapid signallingin
excitable cells principally. Once activated by a neuroffansmitter they may open or close, therefore changing the permeability of the plasma membrane.Catalytic
receptors (ex: the EGF receptor) when activated act directly asenzymes. They are transmembrane proteins
with
an intracellular domain actingas tyrosine protein kinase.
During the last 5 years, more than 100 different G
protein-coupled
receptors (ex: adrenergic, TRH,VIP
receptors, etc.) have been cloned and sequenced (Birnbaumer et al., L990; Savarese and Fraser,1992). Current models for the secondary and tertiary sffucture of G protein-linked receptors are basedin
large part on the known
folding
patternof
an ancient retinal-linked protein, bacteriorhodopsin, a proton pump, that is foundwithin
the purple membraneof
Halobacterium halobium. This pigment, which is not bound to any G protein, has seven s-helices which can ffansverse the membrane.All
the G protein-coupled receptors belong to a superfamily of proteins that also span the plasmamembrane
seven times as judged by hydropathy analyses. They all have an extracellular amino terminus and an intracellular carboxy terminus.Not
surprisingly the sequence homology between some different receptors is rather low, excepted
in
their transmembrane spanning regions. The extremities showlittle
homology. This islikely
the reason to the variable ligand and G protein specificity.3. Heterotrimeric guanine nucleotide-binding proteins
The guanine nucleotide-binding proteins (G proteins) act as a
switch
that controls and transmits ttre informationfrom
receptorsto
a varietyof
intracellular effectors, as suggested first by Rodbell and coworkers
in I97I.
At
least 40 different hormones and neurotransmitters act through the activationof
G proteins.A
single signal can activate different receptor types, whichin
turn can activatemultiple
G protein molecules, thus amplifying the ligand binding event. Moreover, one activated G protein may be capableof
interactingwith
many effector proteins that furtheramplify
the signal. The known effectors whoseactivity
is modulated by G proteins include adenylyl cyclase,cyclic
GMP phosphodiesterase of photoreceptor cells, phospholipases C and A2, aswell
as some K+, Ca2+ and Cl- channels (see Birnbaumer et al., 1990 for review). Each effector modulates the concentration of different intracellular messengers.In
addition each messenger can modulate the activity of other inffac- ellular messengers. Because a single receptor subtype can be coupled to multiple effectors andmultiple
receptor subtypes can activate a single effector, the G pro- tein-coupled interactions form complicatednetworks
(fig. 4).Signal ffansducing G proteins are part of the GTPase superfamily wittr variable functions which have
in
common theirability
to bind andhydrolyze
GTP.
After
solubilization from membraneswith
appropriate detergents G proteins seem to behavelike
a monomerof
approximately 100 kD. Each monomer is composed ofthree distinct subunits,
cr, F and T separable by sodium dodecyl sulphate-polyacrylamide gel elecffophoresis (SDS-PAGE)if
a reducing agent is used.A1 A2 A3 Agonists
]*\*L,,','.41
liiiiffiE#
l:iii:i.11!iiiiii!!!3:lIiiÊijjiÈIilljiiill
ffiÆ ffiffi
lÊgryReceptors
G proteins
Effectors
SMI Izl <+ SM2€ SM3 Second Messengers
Fig.
4. Thesignalling network.
Forclarity
only positive effects are shown. See textfor
explanation.The atpha subunit (varying
from
39 to 52 kD) is the essentialpart
of the G protein (see Stryer 1986; Spiegel L987;Neer and Clapham, 1988; Taylor 1990;Birnbaumer et al., 1990;
Dolphin, l99l;
Simonetal.,l99l
for review).It
hydrolyzes guanine nucleotides and interact
with
both receptors and effectors.At
present, the G protein
family
is known to contain at least 16different
genesthat
encode
s subunits, four
that encode B subunits (35-36kD)
and multiple genes encoding ysubunits (8-11kD).
Different G proteins are distinguished by their cxsubunits, though there are also subtle sffuctural and functional differences
in
some F atrd y subunits. G proteins have been divided
in
sub-classes (see below).3.L. Mechanism of G protein activation.
G proteins cycle between an inactive GDP-bound and an active GTP- bound state. When GDP is bound,
c
associateswith
p/y subunits to form an inactive Gopy complex that is membrane bound. In the presence of the signal molecule, the receptor is occupied and a subtle conformational change of thes
subunit occurs. GTP takes the place
of
GDP and the alphasubunit
isdissociated from the complex and activates the effector. The activation stops when GTP is
hydrolyzedto
GDP by the subunita
itself, then thes
subunitreassociates
with
Bly, and the cycle is completed (fig. 5).Inac:tivc statc
GDP
Pi
H GTP
Receptor activation
GTP GDP
+
I
t
I
Activation of effectors t(
Fig.
5. Mechanismsof
Gprotein activation.
See textfor
explanation.Activc state
Usually, the activation of the effector is mediated by the dissociated subunit cr. However, in a controversial series of experiments,
it
was observed that Biy subunits were capable of opening a muscarinic K+ channel (Logothetis et al.,L987), by activating PLA2
(Kim
and Clapham, 1989;Kim
et al., 1989) and producing arachidonic acid, whose metabolites affect K+ channels function. This observation indicates that the role of the B/ycomplex may be not resfficted to anchoring the cr subunit to the plasma membrane as first described. Moreover, G proteins can be precisely modified byfatty
acids (polyisoprenylation,myristylation,
farnesylation, see e.g. Linder etal.,
I99L). These post-transcriptional modifications are believed to anchor the cx subunits to the plasma membraneo and hence to facilitate the formation of the heterofrimer.
The use of nonhydrolyzable
GTP
analogues is often required to assessif
a given
biological
event proceeds through the activationof
a G protein.Another important test can be performed by adding to the cells the anion AlF4-, which sffucturally mimics the anion PO+-3 and thereby can associate wittr GDP and
form
a complex reminiscentof
GTP. Moreover, some G proteins are the target of toxins which modulate their function (see below).3.2. Sub-classes of heterotrimeric G proteins 3.2.1. The G, sub-class
G., the ubiquitously distributed guanine binding protein which activates
adenylyl
cyclase has been intensively studied.'Western blots after SDS-PAGE have indicated the presenceof
2 bands, one of 45kD
and one of 52kD.
Fourdifferent
cDNA
were found, the four differentG.a
being generated by alternative splicingof
a single gene (Kozasa et al., 1988).Many different receptors (see Birnbaumer et al., 1990) are coupled to G., including receptors which bind
VIP,
B-adrenergic,D-1
dopaminergic,M-2
muscarinic, A-2 adenosine, S-2 serotonin, H-histamine,LH,
FSH, TSH, MSH, CRF, GRF, chorionic gonadotropin, cholecystokinin, PTH, calcitonin, some prostacyclins, secretin, glucagon, andACTH. Activation of
G, leads to an increase of the intracellularcAMP
level.In
addition to stimulating adenylyl cyclase, G. alsodirectly
activates voltage-dependentcalcium
channels of theL-type
(Mattera et al., 1989).G. is a subsffate
for
choleratoxin,
which ADP-ribosylates the q, subunit and reduces itsintrinsic
GTPase activity, so the G, protein is continuouslyactivated (Cassel and Selingeg 1977).
3.2.2. The Gi sub-class
G1 appears to be as ubiquitously distributed as G..
Three different
G1coded by a different gene (Itoh et al., 1988). Gircl and G13û are 94Vo identical
in
their amino acid sequence and they are 88 and857o identical, respectively toGizo'.
G12 proteins can be activated by adrenergic og,
dopaminergicD-2,
muscarinic
'dZ, GABAB, S-1 serotonin, opioid,LH,
somatostatin, angiotensinII,
thrombin, bradykinine, neuropeptide Y, neurotensin, platelet activating factor, some prostaglandins,V-l
vasopressin, and adrenergic cr-1 receptors. Theexistence of
multiple
formsof
oq raised the question of which protein regulates which effector function.In
addition of itsinhibitory
effect on adenylyl cyclase, Gir_t can also,activate potassium channels (VanDongen et al., 1988; Yatani et al.,1988). Interestingly Gis (but not Gir and Giz) is also found on the Golgi apparatus where
it inhibits
the buddingof
secretory vesicles (Burgoyne, L992).Gl proteins also affects adenyl cyclase, but
in
conffast to G, the resultof
the activation
of
Gi is aninhibition of adenylyl
cyclase. Gi proteins aresubsffates
for
pertussistoxin (Ui,
1984) which, by ADP-ribosylation uncouples G' frominhibitory
receptors. As a consequence, cAMP levels are increased, asin
the case of the ADP-ribosylation
of
G, by cholera toxin.While
Gi and G. G subunits clearly differ, the F and Tsubunits of purified G. and G' appear to be identical.It
has been shown that B/yis even a betterinhibitor
of adenylyl cyclase than G1c (Katada et a1., 1984).It
has therefore been suggested thatinhibition of
adenylyl cyclase is due to a direct effect on G, of the Biy complex releasedfrom
activation of Gi (Gilman, 1984). However this isstill
matter to debate.
3.2.3. The G, sub-class
The G protein involved in visual transduction has been called
transducin
(Stryer, 1986).Q (lg kD)
is thelink
between thelight
receptor (rhodopsin) andcGMP
phosphodiesterase (the effector) exclusively in rod and cones cells.Cyclic GMP maintains plasma membrane sodium channels of rod and cone cells
in
an open state, thereby regulating synaptic transmission. Thus cGMPhydrolysis is the crucial event
in
visual transduction.Two different ffansducins exist: one (Gtr) is present in rod cells, the other
(Gd in
cone cells (Grunwald et al., 1986). Transducin can be ADP-ribosylated by bothcholera
(which activatesit)
and pertussis (which uncouplesit from
rhodopsin) toxins.3.2.4. The Go sub-class
This G protein is expressed in high levels in mammalian brain (Sternweis and Robishaw, 1984). Goc represents a 39
kD
species that is the major pertussistoxin
targetin brain tissue, whereit
may comprise as much as l7o of total membrane protein. Its Biycomplex is indistinguishable from that ofQ.
Its functionin
signal ffansduction has not yet been clearly clarified (The"o"
of Gostands
for other). It
may be coupledwith
the muscarinic acetylcholine receptor,a-2
adrenergic, S-2 serotonin, the y-aminobutyric acid receptor, neuropeptideI
and the opioid receptor.
It
activates K+ channels andinhibits Cah
channelsphosphoinositides metabohsm.
It
has been proven that two different mRNAs (and hencetwo
Go proteins, Go1 and Go2) generated by alternative splicing of a single gene exist (Tsukamoto et al., 1991).3.2.5. The other subclasses of G proteins
Gop (Jones et al., 1989) is expressed exclusively
in
olfactory neuro- epithelial cells whereit
stimulates adenylyl cyclase.It
has 9OVoanino
acididentity with
G, andis
atargetfor
cholera toxin.Gn,
often
called Gn, can activatePLC
(Smrcka et al., 1991). PLC catalyses the hydrolysis of phosphatidylinositol bisphosphate(PIP)
to inositol 1,4,5-trisphosphate (Ins(1,4,5)P:) plus diacylglycerol (DG) as describedin
fr9.2.PLA2 stimulates the production
of
arachidonic acid (Axelrod et al., 1988).A
Gn response via the activation of PLC is observed in neutrophils stimulated with the chemoattractant fMLP. This response is clearly pertussistoxin
sensitive(Nakamura and
Ui,
1985). However,in
other cell types (e.g., pinritary cells stimulatedwith
TRH,Martin
et al., 1986), the response is pertussistoxin
insensitive.To complete this enumeration
it
is convenient to mention that some other G proteins, each encoded by a different gene, have been recently discovered.They were named
G"
(Fong et al., 1988),Gtt,
Gtz,G6,
Grc, G15 and G16.Their exact function has
still
to be clariûed. However G11 and G14 are also believed to activate PLC. They belong to the Gn class.4. IWo important effectors coupled to G proteins 4.L. Phospholipase C
The generation
of
second messengers from phosphatidylinositol phosphates (see below)is
catalyzed by enzymes from the phospholipase Cfamily
(see Meldrum etal., I99I for
review).PLCs
are phosphodiesterases which hydrolyze the glycerophosphate bond of intact phospholipids to generate DG and aqueous inositol phosphates, including Ins(1r4r5)Ps. Four types of PLCsin
mammalian tissues have been characterized(u, F,Y-d
ô).All
are producedby a different gene and share
little
sequence homology (Ryu et al., 1987; Rhee et al., 1989), however three of them contain twohighly
conserved sequences that may represent common catalytic and/or regulatory domains.All
four enzymes(M.
between62 and 154Kd)
are able to hydrolyze three coûlmon phospho- inositides, phosphatidylinositol (PI), phosphatidylinositol4-phosphate (PIP) and phosphatidylinositol 4, 5-bisphosphate (PIPz).They
are Ca2* -dependentproteins
and exist both as soluble and membrane associated proteins. Recently four newPlC-related
cDNAs were cloned and sequenced (see Rhee, 1991for
review),with
high similaritieswith
the previously discovered types. They were named P2, ^(2, ô2 and ô3.A
PLC gene foundin
drosophila, norp A, closely resembles the PLC-B type (Bloomquist et al., 1988).PLCs can be regulated by phosphorylation, either
in
a negative way orin
a positive fashion. Some groups have observed that PLCs can be phosphorylated by PKC, which decreases the agonist-induced PIP2 hydrolysis and
C**
phosphorylation of PLC
itself
or of the G protein coupled toit.
cAMP may also exert aninhibitory
effect on the formation ofinositol
phosphates.In
addition,it
has been shown that cells treated
with
growth factorslike
EGF and PDGF increase both the tyrosine and serine phosphate content of PLC-y1 exclusively, and that tyrosine phosphorylation correlateswell with
the increased turnoverof PPz(Huckle
eta1.,1990). These results suggest ttrat PLC-y1 is the isoenzymeof
PLC ttrat mediates PDGF and EGF phospholipid hydrolysis. The PLC isozyme activated byTRH,
a major activator of PRL secretion in pinritary cells seems to be PLCp, which isitself
activated by Gq and/or G11 (Bernstein et al., 1992).4.2. Atdenylyl cyclase
This enzyme is found
in all
mammalian tissues.It
is coupled to two G proteinswith
opposite effects: G, stimulates the enzyme whereas Gl inhibitsit.
The
utilization
of the diterpeneforskolin,
a direct activator of adenylyl cyclase (Seamon et a1., 1986) that can be covalently coupled to an agarose maffix, has allowed the purif,cation of the protein.B oth
calmodulin-sensitive
andcalmodulin-insensitive forms of
adenylyl cyclase have been identified in brain andin
other tissues (Rosenberg and Storm ,1987; Minocherhomje et al., 1988; Gao and Gilman, 1991).A
solubleform
stimulated by calmodulin but not coupled to any G protein (Gross et al.,1981) has also been reported. So far four mammalian adenylyl cyclases have been cloned and were named
I, II, m
and IV. Only type I is calmodulin sensitive(Thng
et
al., 1991). This form is inhibited by the ply subunitsof
G proteins.However, type
tr
andIV
are activatedby Biyif
dissociated Gro is also present (Tang andGilman,l99l;
Federman etal.,
1992). Thus the effectsof
Biydepends on the type of adenylyl cyclase under study. This seems an elegant way in which the cell transforms aninhibitor
ofcAMP
production(Gd
into an activator.The different adenylyl cyclases are thought to contain two domains that span the
lipid
bilayer, each domain consistsof
six transmembrane helices. The sffucture is reminiscentof
those that have been proposedfor
several ffansporters and channels(Krupinski
et al., 1989). The estimated molecular masses of these formsfall in
the rangeof
120-150 Kd.Stimulation of
AC,
mediated byC*+
acting via calmodulin, is the longest established example of potentialpositive 'crosstalk'
between theC**
and
cAMP-signalling
systems (MacNeil et a1., 1985). However, a growing number of reports claim that physiological concenffationsof C** inhibit
adenylyl cyclase
in pituitary
cells, NCB20 cells and cardiac sarcolemma (Cooper,IggD.
This implies thatC**
can control cAMP production bidirectionally, depending on the typeof
adenylyl cyclase present.We now continue our
trip
down the secretion pathway and discuss some important second messengers, such as ca2*, cAMP, inositolphosphates and DG.5. Calcium ions as cytosolic messenger
Among the second messengers know n,
C**
is the mostwidely
studied.A MEDLINE
search of the year L99I reveals the existenceof
8546 papers on the subject, whereascAMP
was studied o'only" L336 times, and Ins(1,4,5)P3 was practically ignoredwith
143 publications. These numbers can explain bythemselves why we focused on such
ahot
subject. But this is not the only reason.[Ca2*]i homeostasis is
finely
and carefully regulated by a battery of cellular elements (see below), each being exffemely important forlife. lC**li
homeostasis influences
all
the cellular eventscritical for
the functions of our body (secretion, protein synthesis, protein degradation, mitosis, ffanscription, energetic metabolism, etc.).The first insights showing that extracellular calcium is necessary for the liberation of
pituitary
hormones were provided by thework
of Vale andGuillemin ,
in
1967 . They could obtain TSH secretion by increasing the external concentration of K+ ions. Similar results were then obtained for the liberationof
the other pituitary hormones. These observations suggested that calcium entry is a key component
in
the controlof
secretionin pituitary
cells. The secretory response to K+ is due to high permeability of the membrane to this ion(Milligan
and Kraicer, L97A). This leads to a depolarization of the membrane and hence to an entry of calcium which is potential dependent. Further studies have then revealed that
inhibitors
of calcium entry (such as the ion cobalt or verapamil) can block the exit ofpituitary
hormones (Thshjian et al., 1978; Ozawa and Kimura,L982, Tan and Tashjian, L984).
In
themajority of
the tissues tested so far, the basal [Ca2*]i level (thein- facellular
concentration of free calcium) isaround
100nM.
However, the extra- cellular[Ca2*].level
isaround I mM.
Thisgradient
presents cellswith
an opportunity: the cytosolic concentration can be abruptly raised forsignalling
purposes by transiently opening calcium channelsin
the plasma membrane orin
an inffacellular membrane. As a consequence,
C*+
rushes into the cytosol, dra- matically increasinglc**liand
activating Ca2*-sensitive responsesin
the cell.For this signalling mechanism to work, [Ca2*]i
under
basal conditions must bekept
low, and this is achievedin
several ways (see below).If
[Ca2+]i is elevatedfor
a prolonged timein
the cells, this could resultin
disruptionof
the cytoskeleton,DNA
fragmentation (Onenius et al., 1989), and the calcium ionwill
precipitate as hydroxyapatite, due to the presence of high amounts of phosphate estersin
the cytosol.lC*\iincreases
are essentialfor
many cellular functions as already mentioned, however the increase should not be too high (no more than a
few pM)
and not be prolonged too much. The major regulatory systemsof
[Ca2+]i are illusffatedin
fig. 6. Cells keep their [Ca2*]ilow
by three essential mechanisms (Carafoli, 1987):1) by reversibly
complexingc**
to cytosolic proteins.2)by
extruding activelyC**
from the cytosol to the external medium.3) by sequesteri
ngC**into
speci ahzedorganelles.Ca2+ channels
ER
(calciosome)
mitochondria
Fig.
6. Elementsinvolved in the regulation of
[Ca2+]; homeostasis.See text
for
explanations.rca2l e 1mM
li - 0.1 pM
lca 2+
5.L. Cytosolic Ca2*-binding proteins
The role of the soluble
Cah-binding proteins
is not only tobuffer
thelc**li,but
also to feel the changesin
[Ca2*]i. Parvalbumin is very abundantin
muscle cells (up to 2
mM)
and has no apparent function other than to bufferC**.
On the other hand e.g calmodulin and troponin C process the signal by changing their conformation. These proteins bind
(with
highaffinity)
usually a fewC**
ions (2 to 4). These
C**
modulated proteins contain repeat domains that bindC**
selecrively andwith high
afflnity. Each domain consist of a loopof
10-12 amino acid residues, flanked by two c-helices perpendicular to each other.C**
binds
into
the loop.This
structural pattern, first seenin
the crystal sffuctureof
parvalbumin, has been called the"E-F"
hand. The number of proteins which possess such domains forC*+
binding is not farfrom
200.Calmodulin
(17Kd), is the most important sensorof
[Ca2+]; (Manalan andKlee,
1984; Cox, 1983).It
is present in relatively high amounts in eukaryotic cells (10pM),
and interactswith
a varietyof
cellular enzymes, regulating their activity. The human genome contains at least three divergent genes coding an identical calmodulin protein (Fisher et al., 1988). This suggest that calmodulin is crucial forlife
and is underhigh
selective pressure to avoid any mutation of its sequence. Among the proteins activated by calmodulin we find adenylylcyclase,
cAMP
phosphodiesterase, phosphorylase b kinase, Ca2*-ATPase of the plasma membrane, etc.5.2. Proteins that transport C*+ through membranes
The
transport
ofC*+
is achieved by membrane bound proteins. ThoseC**-tansporting
systems are presentin
the plasma membrane, mitochondria, sarcoplasmic reticulum, endoplasmic reticulum,Golgi
vesicles and also in the lysosomes.The plasma mernbrane contains three major systems able to modulate
lc**li,namely
1) a specific Ca2*-ATPase, 2) aNa+/Ca2* exchanger and 3) many differentC**
channels (fig. 6).5.2.t The Ca2*-ATPase
All
eukaryotic cells have aCa2+-XlPasein
their plasma membrane that uses the energy ofAIP
hydrolysys to pumpC**
out of the cytosol (Schatzmann, L982). Thispump
(a single polypeptideof
128Kd)
can bind calcium wittt high specificity and high affinity, its Ko being near 1pM.
When [Ca2+]i increases,C**
binds to calmodulin which is an activator of the AIPase, and the ion isextruded from
the cell.A
Ca2+-ATPase pump,different
from the one presentin
the plasma membrane is also foundin
the membrane of the specializedintracellular compartment
and also plays an important partin
keeping [Ca2*]i low. This pump is active evenif
[Ca2+]i is around basal level and enables the compartment to take up large amountsof C*+
from the cytosol.In
the lumen of theinffacellular
compartment,C**
is loosely bound tolow-affinity/high
capacity Ca2+-binding proteins similar to e.g. calsequestrin, calreticulin, etc.5.2.2.The Na+/C*+ exchanger of the plasma membrane
To reduce [Ca2*]i, muscle and nerve cells have an additional element
in
their plasma membrane that couples the efflux of
C*+
to theinflux
of Na+ (Vigne et al., 1988). This exchanger, sensitive to amiloride and to phosphorylaton by PKC, has alow affinity for C*+
and therefore begins to operate efficiently only when [Ca2*]i reaches values significantly higher than 100 nM. Its structure remains largely unknown.5 .2.3 .
Calcium channels
Many calcium
channels havealready
been described. Channel proteins allow the passivediffusion
of ions, which is governed by electro- chemical gradients. They are transmernbrane proteins andformpores
in thelipid
bilayer through which ions can travel. The mechanismof
channel openingdepends of the type of the channel considered.
Calcium channels can be voltage-dependent or voltage-independent.
The members of this latter
family
are predominately foundin
non-excitable tissues and arepoorly
definedyel
They are activated by receptor occupancy and have therefore have been called ooreceptor-operated channel". This denomination is rather confusing because voltage-dependent calcium channels can also be opened by receptor occupancy.In
the field of this introduction wewill
not be interestedin
the voltage-independent channels (however see Hallam and Rink,1989;
Rink,
1990; Futney, 1990; Demaurex et a1., L992), but we focus on the channels that are largely present in pinritary cells, the voltage-dependent calciumVoltage-dependent
calcium
channels (seeMiller,1992 for
a recent review) are predominantly foundin
excitable tissues, such as nerve and muscles.They are opened by
depolanzationof
the plasma membrane. They are characterizedby highion
selectivity and voltage sensitivity. Four classesof
voltage-dependent calcium channels have been caracterized due to their
pharmacological and electrophysiological properties: L-type, T:type, N-type and P-type.
L-type
voltage-dependentcalcium
channels(L-VDCC).
L-VDCC
(see Campbell et al., 1988; Catterall, 1988) are the targetof dihydropyridine (DHP)
drugs which can open or close the channel. DHP- sensitive calcium channels are also inhibited by phenylalkylamines and benzothiazepines.It
has been demonstrated that DHP stereoisomers which selectively enhance or decrease Ca2* enffy also modulate the release andproduction of
pituitary
hormones (e.g. Enyeart et a1.,1985; Enyeart et al., 1987;Day and Maurer, 1990).
Most
information
on this channel has emerged from work on skeletal muscle, arich
source ofL-VDCC. It
is composed ofdistinct subunits:
ul
(170Kd), a2lô
(175Kd),
P (52Kd)
andy(32
Kd).All
these subunits have now been purified and sequenced (Tsien et al., 1991). The mostimportant
subunit
is crl., which ishighly
homologous to theo
subunit of the sodium channel. Indeed, some point mutations at precise sites conferC**
channel properties to a Na+ channel (Heinemann et a1.,1992). Thecl
subunitsof
L-VDCC
is thetargetof
DHPs, phenylalkylamines and benzothiazepines. This subunit is also the voltage-sensor of the channel andit
has been shown that assemblies of pure cr subunits canform
a functional channel.In
pituitary
cells, thebiological
system usedin
our laboratory L-VDCCs are activatedif
the cells are depolanzed (by an agonist or during patch-clamp experiments) at values beyond -20mV
the resting potential being near -55 mV.Under nonstimulated conditions, those channels are usually closed in pinritary cells. Once opened, their conductance is near 25 pS. Their activation is rather slow, and the duration
of
the aperture is quite long (some ms), compared to the other VDCCs (the'L
ofL-VDCC
stands for Long lasting). They are blockedby mM
concenffationsof
Cd2+.In
addition to their regulation by the plasma membranepotential,
L-VDCCs
are regulated by theprotein G,
(Yatani et al., 1987) and the channel is a subsffate forPKA
andPKC
(Chang et al., 1991). The channel is inactivated byC*+ itself
(feedback regulation).In
clonalpituitary
cells,C**
enffy during the action potential (see below) occursprincipally
throughL-VDCC.
However those cells also contain calcium channels of the T:type (T-VDCC, Armstrong and Matteson, 1985).T type
voltage-dependentcalcium
channels(T'VDCC).
In
pituitary
cells, only one or two percent of those channels are opened at the resting potential.Their
conductance is transient (less than 1 ms, the"T" of T-VDCC
standsfor
Transient) and is smaller (10 pS) than that of the L-VDCCs.Their sffucture is
still
unknown. They are insensitive to DHPs and Cd2+, but areblocked by Coh
ions. They may be importantfor
the beginning of the action potentials inpituitary
cells.N-type
voltage-dependentcalcium
channels(N'VDCC).
N-channels are
widely
distributedin
the Nervous system. They areacrivared at high threshold, like
L-VDCC.
They are blocked by ro-conotoxin, but are insensitive to DHPs. They do not seem to be presentin
GH3B6 or GHaCI cells.Little
is known about their sffucture.P-type voltage-dependent
calcium
channels(P-VDCC).
P-channels are insensitive to DHPs and co-conotoxin and are predominant in Purkinje cells. They are blocked by the venom of the
spiderA.
apertawith
ahigh
affinity (Kd <
10nM).
Here again,little
is known about the structure.5.3. Intracellular stores
5.3. 1 .
Endoplasmic reticulum
The endoplasmic reticulum (ER), is the main organelle able to buffer
lC**liin
non-muscle cells.It
plays the roleof
a reserveof C**.
This store is sensitiveto
Ins(1.r4r5)Pr (Benidge andkvine,
1984). However some studies have shown that only partof
theC**
containedin
the organelle is released by Ins(1,4,5)P3 (Burgess etal.,
1984; Prentki et al., 1985; Biden etal,
1986). Thus the ER comprises Ca2* storage elementswhich
are Ins(1,4,5)P3 responsive and others which are Ins(l,4,S)P3unresponsivewith
regardn C**
ûberation. The Ins(1,4,5)P3 uffesponsive stores can be modulated by caffeine (Thayer et a1.,1988) or
thapsigargin
(Thastrup et al., 1989).The ER and the sarcoplasmic reticulum (SR), its counterpart
in
muscle cells, possess a specific Ca2*-ATPase (100 Kd), different from that of the plasma membrane, usedfor
the uptakeof C*+.
The calcium is released back to the cytoplasmby a channel opened byIns(l
,4,5)P3in the endoplasmic reticulum and sensitive to ryanodinin
muscles.These observations generated an increased interest for the purification
of
the part of the ER which is Ins(1,4,5)P: sensitive (Volpe et al., 1988; Krause et
aL., 1989; Rossier et al., 1989).
It
was suggested that this portion of the ER couldform
organelles. They received the sweet nameof
"calciosome". They comprise a specific combinationof
Ca2*-ATPaseswith
second messenger Ins(1,4,5)P3- operatedC**
release channels, andahigh
capacityC**-binding
protein similarKrause et al., 1990).
In myeloid
cells this protein was identified ascalreticulin
(Treves et al., 1990).
The major
criticism
one could argue against the "calciosome" theory is that the assembly of molecular elements obtainedin microsomal fractions
may not bereliably
reporting the real functional and sffuctural context of theIns( 1,4,5)P3 responding store.
The intracellular receptor that mediates the effect of Ins(1,4,5)Pg was
first
purified, due to itsaffinity
for heparin and concanavalin,fromrat
cerebellum and found to correspond to a26O Kd phosphoglycoprotein (Supattapone et al.,1988a). In the brain the Ins(1,4,5)P3 receptor is
highly
concenffatedin
cerebellar Purkinje cells andin few
other types. Reconstitution snrdies have revealed thatthis receptor
molecule includes theion
channel activatedby
Ins(1'4'5)P3binding
(Fenis et a1., 1989). The binding of Ins(1,4,5)P3 to thetetramer
is cooperative and requires at least the binding of three Ins(1,4,5)P3 molecules (Meyeret
a1.,1983). The Ca2+ channel binds Ins(1,4,5)P3Kd
in the nM range)and opens rapidly. The release of
C**
is aquantal
process as seen in intact cells (Muallem et al., 1989) andin
vesicles reconstitutedwith
Ins(1,4,5)P3 receptor (Ferriset
aL.,1992).Using immunological techniques, the receptor is found